<ul>
<li>PICO = population, intervention, comparator, outcomes; CKD = chronic kidney disease; NSAIDs = nonsteroidal antiinflammatory drugs.</li>
</ul>

<p>â€  Moderate evidence is in support of the efficacy of pegloticase, but due to cost, safety concerns, and favorable benefit-to-harm ratios of other untried treatment options, the recommendation is against using pegloticase as first-line agent.</p>

<h1>Table 3. Recommendations for all patients taking urate-lowering therapy (ULT)*</h1>